Literature DB >> 12848952

The epidemiology of autoimmune diseases.

Glinda S Cooper1, Berrit C Stroehla.   

Abstract

Autoimmune diseases are among the leading causes of death among young and middle-aged women in the United States. Incidence rates vary among the autoimmune diseases, with estimates ranging from less than one newly-diagnosed case of systemic sclerosis to more than 20 cases of adult-onset rheumatoid arthritis per 100,000 person-years. Prevalence rates range from less than 5 per 100,000 (e.g. chronic active hepatitis, uveitis) to more than 500 per 100,000 (Grave disease, rheumatoid arthritis, thyroiditis). At least 85% of thyroiditis, systemic sclerosis, systemic lupus erythematosus, and Sjögren disease patients are female. Although most diseases can occur at any age, some diseases primarily occur in childhood and adolescence (e.g. type 1 diabetes), in the mid-adult years (e.g. myasthenia gravis, multiple sclerosis), or among older adults (e.g. rheumatoid arthritis, primary systemic vasculitis). Ethnic and geographic differences in incidence of specific autoimmune diseases have been documented, but specific groups may be at higher risk for some diseases and lower risk for other diseases. The incidence of type 1 diabetes increased but the rates of rheumatoid arthritis declined over the past 40 years. Thus although there are commonalities, there are also important demographic differences between diseases. Disease-specific research, as well as studies that focus on potentially related diseases, needs to be conducted.

Entities:  

Mesh:

Year:  2003        PMID: 12848952     DOI: 10.1016/s1568-9972(03)00006-5

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  219 in total

1.  Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus.

Authors:  Faith M Strickland; Anura Hewagama; Qianjian Lu; Ailing Wu; Robert Hinderer; Ryan Webb; Kent Johnson; Amr H Sawalha; Colin Delaney; Raymond Yung; Bruce C Richardson
Journal:  J Autoimmun       Date:  2011-12-03       Impact factor: 7.094

2.  Uveitis and neurological diseases.

Authors:  L K Gordon
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

Review 3.  Does vitamin D affect risk of developing autoimmune disease?: a systematic review.

Authors:  Martin A Kriegel; JoAnn E Manson; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2010-11-02       Impact factor: 5.532

4.  Maternal history of autoimmune disease in children presenting with tics and/or obsessive-compulsive disorder.

Authors:  T K Murphy; E A Storch; A Turner; J M Reid; J Tan; A B Lewin
Journal:  J Neuroimmunol       Date:  2010-09-22       Impact factor: 3.478

5.  Application of serum NY-ESO-1 antibody assay for early SCLC diagnosis.

Authors:  Jihua Yang; Shunchang Jiao; Jingbo Kang; Rong Li; Guanzhong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 6.  Modulation of autoimmune rheumatic diseases by oestrogen and progesterone.

Authors:  Grant C Hughes; Divaker Choubey
Journal:  Nat Rev Rheumatol       Date:  2014-08-26       Impact factor: 20.543

7.  Familial autoimmunity in neurological patients with GAD65 antibodies: an interview-based study.

Authors:  Sergio Muñiz-Castrillo; Alberto Vogrig; Clémentine Montagnac; Bastien Joubert; Marie Benaiteau; Olivier Casez; Hugo Chaumont; Lucie Hopes; Hélène-Marie Lanoiselée; Vincent Navarro; Benjamin Thomas; Renata Ursu; David Gonçalves; Nicole Fabien; François Ducray; Cécile Julier; Jérôme Honnorat
Journal:  J Neurol       Date:  2021-02-05       Impact factor: 4.849

Review 8.  Biochemical markers of aging for longitudinal studies in humans.

Authors:  Peter M Engelfriet; Eugène H J M Jansen; H Susan J Picavet; Martijn E T Dollé
Journal:  Epidemiol Rev       Date:  2013-02-04       Impact factor: 6.222

Review 9.  Sexual dimorphism in predisposition to Alzheimer's disease.

Authors:  Daniel W Fisher; David A Bennett; Hongxin Dong
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

Review 10.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.